| scholarly article | Q13442814 |
| P2093 | author name string | Eyal Zcharia | |
| Aaron B Baker | |||
| Elazer R Edelman | |||
| Israel Vlodavsky | |||
| Tarek Shazly | |||
| Michael Jonas | |||
| Adam Groothuis | |||
| Philip Seifert | |||
| David S Ettenson | |||
| P2860 | cites work | Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 |
| Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway | Q24649727 | ||
| The impact of heparanese and heparin on cancer metastasis and angiogenesis | Q28252958 | ||
| Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury | Q33584566 | ||
| Molecular properties and involvement of heparanase in cancer progression and normal development | Q34088794 | ||
| Endothelial cell functions | Q35189112 | ||
| Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies | Q35673130 | ||
| Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia | Q35799754 | ||
| Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition | Q36111145 | ||
| Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth | Q36205173 | ||
| The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells | Q36322653 | ||
| Atherosclerosis: disease biology affecting the coronary vasculature | Q36684354 | ||
| Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix | Q36772532 | ||
| Overview of physiology, vascular biology, and mechanisms of hypertension. | Q36867222 | ||
| The pathophysiology and burden of restenosis | Q36919095 | ||
| Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty | Q37175241 | ||
| Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression | Q40562955 | ||
| Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells | Q42804318 | ||
| Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial | Q44734591 | ||
| Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior | Q44760488 | ||
| Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study | Q44781952 | ||
| Heparanase activity in cultured endothelial cells | Q45149623 | ||
| Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals | Q46670083 | ||
| Novel Heparanase-Inhibiting Antibody Reduces Neointima Formation | Q63253221 | ||
| Endothelial heparan sulfate is necessary but not sufficient for control of vascular smooth muscle cell growth | Q73821832 | ||
| Heparanase as mediator of angiogenesis: mode of action | Q74101720 | ||
| Heparanase and platelet factor-4 induce smooth muscle cell proliferation and migration via bFGF release from the ECM | Q74208599 | ||
| Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation | Q74299680 | ||
| Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair | Q74479617 | ||
| The role of elastin in aortic valve mechanics | Q74566132 | ||
| Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials | Q78726582 | ||
| Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis | Q79906000 | ||
| Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin | Q80564365 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 380-387 | |
| P577 | publication date | 2008-12-18 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice | |
| P478 | volume | 104 |
| Q39934228 | A method for serial selective arterial catheterization and digital subtraction angiography in rodents |
| Q54599158 | Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor. |
| Q58707225 | Algal Polysaccharides as Therapeutic Agents for Atherosclerosis |
| Q33705695 | Augmentation of postswelling surgical sealant potential of adhesive hydrogels |
| Q34426913 | Elevated urine heparanase levels are associated with proteinuria and decreased renal allograft function |
| Q35778023 | Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia |
| Q35023208 | Genetic dissection of quantitative trait Loci for hemostasis and thrombosis on mouse chromosomes 11 and 5 using congenic and subcongenic strains |
| Q43158794 | Glucose-induced endothelial heparanase secretion requires cortical and stress actin reorganization. |
| Q51216476 | Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics. |
| Q41728328 | Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis |
| Q33912429 | Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling |
| Q54568652 | Heparanase enhances nerve-growth-factor-induced PC12 cell neuritogenesis via the p38 MAPK pathway. |
| Q38080632 | Heparanase in inflammation and inflammation-associated cancer |
| Q33761544 | Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice |
| Q33834001 | Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels |
| Q34876266 | Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice |
| Q28264895 | Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance |
| Q38985052 | Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy |
| Q42587945 | Heparanase: From basic research to therapeutic applications in cancer and inflammation |
| Q28275259 | Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications |
| Q27025052 | Involvement of heparanase in atherosclerosis and other vessel wall pathologies |
| Q35115023 | Loss of function in heparan sulfate elongation genes EXT1 and EXT 2 results in improved nitric oxide bioavailability and endothelial function |
| Q37683359 | Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow |
| Q36542354 | Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression |
| Q47844124 | Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function |
| Q38311837 | Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system. |
| Q39572643 | Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis |
| Q51640772 | Serum heparanase concentration and heparanase activity in patients with retinal vein occlusion. |
| Q39874611 | Smooth muscle cells orchestrate the endothelial cell response to flow and injury |
| Q41421987 | Syndesome Therapeutics for Enhancing Diabetic Wound Healing |
| Q38337182 | Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of Toll-like receptor signaling and nuclear factor-κB, hypoxia-inducible factor-1A, and ETS transcription factors |
| Q33770777 | Versatile role of heparanase in inflammation |
Search more.